Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-19-000401
Filing Date
2019-04-22
Accepted
2019-04-22 18:37:01
Documents
1
Period of Report
2019-04-12

Document Format Files

Seq Description Document Type Size
1 e618389_3-vdb.html 3  
1 e618389_3-vdb.xml 3 2184
  Complete submission text file 0001193805-19-000401.txt   3585
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMMUNIC AG AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address
van den Bossche Jan (Reporting) CIK: 0001774052 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36201 | Film No.: 19760333